Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ABT-089

Known as: A-87089.0, ABT 089, ABYT 089 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Some rats [sign-trackers (STs)] are especially prone to attribute incentive salience to reward cues, relative to others [goal… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Rationaleα4β2 Neuronal nicotinic receptors (NNRs) are implicated in the pathophysiology of attention-deficit/hyperactivity… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2008
Highly Cited
2008
Because modulation of cortical cholinergic neurotransmission has been hypothesized to represent a necessary mechanism mediating… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2007
Review
2007
Attention deficit/hyperactivity disorder (ADHD) is the most commonly diagnosed neurobehavioral disorder in children and… Expand
Highly Cited
2006
Highly Cited
2006
BACKGROUND This pilot study was designed to evaluate ABT-089, a neuronal nicotinic receptor partial agonist, as treatment for… Expand
Review
2004
Review
2004
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride salt] is a selective neuronal nicotinic receptor (NNR… Expand
Highly Cited
1998
Highly Cited
1998
Abstract Increased distractibility is associated with both Alzheimer’s disease and attention deficit disorder. The present study… Expand
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1997
Highly Cited
1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride], a novel ligand at neuronal nicotinic acetylcholine… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 2
1997
1997
2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine, ABT-089 (S-4), a member of the 3-pyridyl ether class of nicotinic acetylcholine… Expand
Highly Cited
1997
Highly Cited
1997
Accumulating preclinical and clinical evidence data suggests that compounds that selectively activate neuronal nicotinic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3